Special situation · 108 dossiers

AI-chip theme but momentum LAGGARD (rank 88%), NVDA ARM-PC structural x86 threat + 108x P/E contested thesis, weakest cluster name.

Operational inflection now visible: Q1 (2026-05-07) printed record adjusted EBITDA and a revenue beat ($308.8M vs $285.2M est), with a reaffirmed 2026 outlook and FCF-positive H2 guide as the Conway extract/RTD platform turns capex to…

BTC-miner-to-HPC re-rate re-accelerating: 1 GW Kentucky AI campus (2026-05-26) + six PT raises to $28–42 pushed through a Q1 revenue miss. The binary now is a named hyperscaler tenant landing vs. the 2026-06-02 NY data-center moratorium…

Post-ADVA turnaround CONFIRMED on the 2026-05-04 Q1 beat non-GAAP GM 43.0%, revenue +15.5% YoY, optical +24% on hyperscaler DCI demand, non-GAAP EPS $0.14. The inflection fat-pitch already ran ~$7→$20; now MATURING and consolidating inside…

Legacy CDN→security/AI-compute re-rating (+137% off the $69.78 low) is MATURING and rolling: AKAM fell -6.08% to $149.32 on 2026-06-05 on a buy.77), with Delivery -16% YoY and a $2.6B convert overhang. Real narrative, spent leg watch,…

Healthcare-staffing cyclical recovery, breaking out: AMN +101% YTD to 52-wk highs ~$32 as temp-nurse demand inflects (Jefferies +3.6% w/w; CCRN travel/allied +7% q/q) and EBITDA recovers. But price sits ~25% above the $25 avg analyst PT on…

Record 2026-05-13 Q1 (sales +29.7%, op profit +36.5%) but FY2026 guide held FLAT, not raised a third straight time the beat-and-raise engine stalled. Shares topped ¥5,149 that day, down ~12% to ¥4,502 since. Hoka guiding HSD next quarter;…

Cash-rich life-sciences-tools laggard (~$10.90/share net cash, no debt) bouncing off its $15.93 low after a May 6 impairment-and-guidance-cut gap-down. The leg here is activist/value-unlock (Politan ~10%, investor day pending), not an…

Big-box retailer back to positive comps (+2.0% Q1 FY27, 2026-05-28) and repositioning as the physical storefront for the AI-glasses/VR cycle via the Meta Lab rollout (50+ stores, June). But the easy +24% recovery off the April ~$60.50 low…

China-AI re-rate has stalled: BABA/Tencent/PDD plunged 2026-05-31 while US AI ripped. Q1 (2026-05-18) showed AI >50% of revenue and Cloud +33% but the stock went flat. Price pins the 200-day (~$123) under a falling 50-day ($139).…

Left-for-dead hydrogen fuel-cell name re-rated ~+80% off $3.39 (2026-05-01) on a real Q1 turn 3rd straight quarter of positive gross margin (14%), 36% opex cut. But it has churned at ~$6.06 for two weeks above every analyst PT, with a…

Post-ASMS product-cycle pop peaked ~$63 and rolling over (-6%), organic -4.4%, trades above raised consensus wait-for-a-higher-low fade.

Busted ETH/WhiteFiber holdco, not a momentum setup. Both prior break levels gave way on 6/5: BTBT closed $1.64 (-11.4%) and the 27M-share WYFI stake fell with WYFI's -15% to $23.27, while ETH cratered to ~$1,566. The ~36% SOTP discount…

Casual-dining re-rate, not an ignition: North Italia (+7%) and Flower Child (+21% sales) scaling ~20% units plus a margin-expansion story drove +42% YTD to all-time highs and a 2026-06-10 JPMorgan upgrade. But ~$75 now sits through the…

Legacy-diner turnaround confirmed by the 2026-06-09 Q3 beat and raised FY26 guide ($3.27–3.30B vs $3.25B est); analyst upgrades clustering (WFC OW $50, Argus $60) into a 9-month-high tape. But the earnings binary already fired, price is…

Blood-safety turnaround now analyst-confirmed: Q1'26 (4/30) hit adj-EBITDA +$4.0M and +$6.2M operating cash on +24% product rev, drawing a BTIG Buy/$4 PT plus France EFS and BCA supply deals. But the 2.7x off the $1.15 low is largely spent…

Grid-power MATURING, GOES story real but Q1 EPS miss, price above every PT, 13.9% short squeeze fuel WATCH a 20-EMA $12 hold.

Geopolitical VLCC super-spike is rolling over: spot ex-AG broke below $100k/day on 2026-06-02, first sub-$100k in 19 weeks, off a $420k+ peak. CMB.TECH's Q2 (~80% fixed at ~$180k/day) is near-locked, but the rate has turned, the Q1…

Managed-care margin recovery off the 2025 ACA blowup: +137% to ~$59, now above the ~$55 consensus PT as sell-side upgrades (DB $80, BofA $74) arrive late confirmation, not a fresh leg. Q1 crushed ($3.37 vs $2.13) yet FY guide only >$3.40…

Resurrected 3D-printing retail narrative is being monetized by management, not traders: $100M shelf (May 22) → $50M raise at $3.05/16.4M shares (June 4), printed straight into the Q1-beat pop. Dilution overhang caps the name; no theme…

GLP-1-fear-reversal + census-recovery re-rate (+70% YTD) is already paid out: spot ~$192 sits below the $193.71 avg PT, ~5% off the ATH, tape flat 3 weeks, Berkshire trimming, no catalyst until the ~early-Aug Q2 print. MATURING toward…

Legacy enterprise-networking name re-rated ~+98% in 3mo on the "Platform ONE/Agent ONE" AI-NetOps story + SaaS ARR +29% YoY. Now MATURING: spot $28.02 sits ABOVE consensus PT ~$26, two CEO insider blocks sold into the high, stock just…

Contested legacy-CCaaS AI pivot, NOT accelerating: AI ARR +68% (~$125M) but core seat revenue only +8% and total growth decelerated to +9% (Q1, 4/30). Price rolling over $26.26 (6/1) → $23.52 (6/5, -10% in 4 days) as Salesforce Agentforce…

Busted Labcorp CRO spin running a real margin turnaround Q1 adj EBITDA +55% YoY, margin +270bps to 7.4%, book-to-bill 1.15x (3rd straight Q >1.1x). But the catalyst is spent: stock 4x'd off $3.97 to ~$15.64, RSI ~80, +51% over the 50-day,…

Cyber/legacy pivot, FY27 guide raised 8-10% but tape MATURING/range-bound, Hold consensus, -3.3% YTD, no momentum breakout. WATCH for a $27.76 — reclaim with the group.

Turbo supplier re-rated into a datacenter/industrial oil-free cooling narrative (Ingersoll Rand + Trane). But the move already happened: +210% YoY to all-time highs (~$32–34), sell-side fully caught up (BWS $42 on 2026-06-01, Stifel $36,…

Defensive med-tech turnaround, MATURING character, no narrative velocity; recovery bounce toward a depressed PT cluster wrong archetype for size.

Post-earnings pop fully round-tripped: HELE fell ~28% from the late-April ~$33.73 spike back to $24.34 (2026-06-06), now resting on the $23-25 analyst PT cluster. Momentum structure broken, no accelerating leg, Q1 FY2027 (~early July)…

AI-server ACCELERATING theme but own setup failed +25% record blowoff round-tripped to ~$49 gap-fill, catalyst spent to ~Sept.

Office/studio REIT special-sit at/above its $12-14 PT cluster, RSI 84 parabolic, ~$566M CMBS maturity wall 2H26 single-name binary, not theme momentum.

Med-device turnaround re-rating banked price above every raised PT, organic only +1.3%, idiosyncratic (no peer cluster); no edge today.

Recognition-phase genomics re-rate that already ran ~96% in a year; now fading from a new $177 high to ~$163 while activist director Corvex/Meister dumps ~$107M into strength and price sits ~13% above the $143.83 avg PT. MATURING with…

Spirit's May liquidation handed JBLU a Florida capacity windfall Q2 RASM guide raised to +9-12%, ex-Spirit routes outperforming. But the same Hormuz-driven fuel spike that killed Spirit ($4.26-4.36/gal, ~40% recapture) caps the bottom…

Aluminum tariff supply-shock + Q1 inflection already drove KALU +156% YoY to ATHs; clean leg ran Feb–Apr. The 2026-06-08 proclamation codifies the 50% core rate through 2027 but adds 15% carve-outs that cap the premium tailwind…

Bitfarms-reborn BTC-miner→AI-datacenter pivot (rebranded 2026-04-06). Re-rate still hinges on signing the first HPC/AI lease none signed. The upsized $400M convert (priced 06-05, ~$7.41 strike) confirmed the funding gap; stock rolled from…

Cyclical staffing inflection printed on the 2026-04-27 Q1 beat (+17–20% gap, first YoY revenue stabilization in 2 yrs; Q2 guided +~4% YoY, AI-consulting pipeline +50%). But the catalyst leg is spent ~$46.55 sits above the $42 analyst PT…

Pension-reversion fat pitch already fired completed Dec 2 2025, ~$767M to the balance sheet, now net-cash >$300M and the re-rate ran to a $14.87 high before a ~32% correction to ~$9.7 (pivot-top sell signal May 6). What's left is a slow…

The +214%-YTD deleveraging + GTA-ramp turnaround is fully recognized and losing its tailwind. Q1 (2026-05-05) resolved the binary bullishly record 74.8 kboepd, 9.5 LNG cargoes, debt-cut target doubled to ~20% but that print drove the run…

Macy's "Bold New Chapter" turnaround printed a clean Q1 beat (EPS $0.13 vs $0.03) and a twice-raised FY guide with growth across every banner, plus a fresh Berkshire stake but it ran to 3-year highs into the print, sell-side stayed…

Bitcoin-miner-to-AI/HPC pivot, but the diversification bounce just round-tripped: MARA gave back the entire $12.44→$15.29 May rally and closed ~$12.32 (2026-06-05, -11.7%) on a Q1 double-miss while BTC broke $62K. No accelerating leg…

Data-center power-distribution pivot (busbars/power delivery into AI racks, ~$120M annualized run rate) is the re-rating story that ran MEI ~3x off its $4.88 low. But it's a loss-making, ~4x net-levered legacy auto supplier now trading…

Medtronic diabetes spinoff repricing as a pure-play automated-insulin-delivery / CGM story; the Abbott dual glucose-ketone exclusive sensor deal (2026-06-03) extends the ecosystem moat. But the Q4 print and the deal both fired the same day…

Managed-care trough-year rotation that ran its first leg and stalled. MOH closed $190.86 (Jun-5), ~+58% off the $121 low, drifting sideways; consensus analyst PT (~$172, Morgan Stanley $167 on Jun-4) now sits BELOW spot the relief rally…

Legacy watch maker re-rated ~+37% in a month to all-time highs ($37.73, 2026-06-08) on a 320bp gross-margin beat (Q1 FY27, ~2026-06-04). But the revenue beat was FX-aided (+8.1% reported vs +4.5% constant-currency) and management pulled FY…

Post-COVID turnaround re-rate cooling, both catalysts public, no life-science-tools cluster confirmation, catalyst desert to ~Aug probe-only at best.

Q1 confirmed the turnaround Aripuanã record 13kt zinc, EBITDA +126% YoY, revenue $888M beat and the stock ran the whole leg to ~$15.75, near its 52-wk high. But the easy re-rate is spent: price now sits AT Citi's twice-raised $16 PT (still…

Broken-tape legacy turnaround pinned at 52-wk lows (~$43, -30% YTD); the May discretionary-rebound bounce failed into a lower low and recent sell-side flow is downgrades (WF $45, GS/JPM $52), not an upgrade cluster. No momentum leg a…

AI-enterprise tag is derivative (VAR, hardware GP guided flat), +1% sales, death-cross intact while +35% above MAs above $103 PT value-trap geometry.

AI-storage sympathy-laggard to DELL, +22% gap to ATH then catalyst spent, FY27 guide only +8%, RSI high-70s cleaner leaders lead.

Water-infra + precast roll-up legacy pivot; +180% over 52wks on record Q1 backlog ($373M WTS) and an ~83% EPS beat (Apr 29). But the trade is MATURING June 5 saw a ~4% rejection off the new $123.49 high to close $117.76, price still…

Beaten-down premium-apparel holdco (Tommy Bahama, Lilly Pulitzer) bounced ~44% off its $30.57 low to $44.12 straight into a binary Q1 print on 2026-06-10 (after close). No accelerating narrative mean-reversion rally now trading above the…

Activist turnaround (Hestia's Wolf as CEO) has played out ~3x off the $8.95 low, pinned near the 52-wk high $17.09 (~$16.72). It's a buyback/cost-cut EPS re-rate with revenue still -3% YoY; Citizens ratchets its PT to $19 — but the…

Margin/buyback/new-CEO rerate, not a narrative leg: Q1 FY27 (2026-05-28) revenue +1% YoY, ARR flat $496M, NRR 97% (from 104%). +14.7% pop on 25% op margin, $100M buyback, DiLullo named CEO. ~$9.25, below 200-DMA, at RBC fair-value PT $9…

Fertility-benefits re-rate now MATURING (mis-themed as biotech) analyst cluster done, avg PT on spot, 8-week catalyst vacuum to the 7/30 print pullback-to-$24, not a chase.

Powersports turnaround leg ($52→$75.25 peak) has played out and is rolling over PII hit a fresh 52-wk high then fell to $66.06 (−4% on 2026-06-05), now below consensus PT $68. MATURING, special-sit catalyst spent (Indian sale closed…

Reciprocal-pivot fundamentals intact (Q1 PSI rev +29% to $109.4M, FY26 guide raised to $495–507M), but the momentum leg broke: shares round-tripped $10.81→$9.26 weekly close (2026-06-05), severing the $9.70 shelf. No hard catalyst until…

Gas rig-reactivation thesis firming operationally: management guided exit-Q2 at 92-95 rigs (avg ~90) toward 100+ by year-end, and EIA lifted 2026 Henry Hub to ~$4.02 (+16% vs 2025). But it's a slow-burn cyclical stock ~$11.74 (06-05)…

Q1 FY26 print (2026-06-04) resolved the binary bearish: PVH −20%+ as the FY EPS guide held only on a one-time ~$100M tariff refund and the 2026 buyback was cut to ≥$300M. A broken legacy-apparel name round-tripped to its 2024 $70 support…

Narrative still broken post-2026-05-05 Q1 (Q2 transaction-margin dollars guided to DECLINE); price stuck below 50/200-day in a death-cross. The 2026-05-29 "beaten-down bounceback" media chatter is bottom-fishing, not a momentum leg.…

Broken legacy-diagnostics downtrend Q1 -10.5% miss + guide cut, near 52w low, below all MAs; value trap, track for a base above $9.92.

Neocloud pivot accelerating and now validated by name: the record $270M Blackwell B300 commitment was disclosed 2026-06-04 as a Together AI deal, with Northern Data's close and a hyperscaler-compete cloud launch both due ~mid-June. But the…

Deleveraging-turnaround re-rate off the $0.81 low, now validated by Constellation Software's ~12.7% stake + board seat, with SabreMosaic AI airline-retailing as optionality. But momentum just rolled: a −10% drop on 6/05 to $1.66 dumped…

Legacy single-digit-multiple EMS re-rating into AMD's AI-server manufacturing arm via the ZT Systems deal; FQ2 detonated the frame (rev $4.01B vs $3.29B, +31.8% EPS beat) and the FY27 $16B target doubles the book. Narrative intact but the…

May's +45% melt-up (Point72 6.2% stake ~05-15, JPM Overweight $13 on 05-22) has round-tripped: SG faded ~$9.63→$7.42 (06-05), back at consensus fair value (~$7.8 avg PT). Faded momentum, no near-term catalyst watch-only.

Q1 +18% rev is Kurt Geiger M&A; organic DTC only +8%, adjusted EPS fell to $0.45 from $0.60. Mature legacy pivot; next real binary is the ~Aug Q2 print, 60+ days out.

Restructuring + AR-pivot, not momentum. The Perplexity AI alliance was killed alongside the Q1 print (2026-05-07, -10.5% gap); CFO exit + 16% layoffs frame a cost-out turnaround; sell-side PTs washed to $6-8. The Illumix AR buy…

Busted-IPO turnaround: down from the $23.50 Sept-2025 IPO to a $5.74 low, now doubled off lows on a Q1 profitability inflection (first GAAP profit, FCF ~+90%, deleveraging to 4.0x). At ~$11.46 it has pushed above the $8.50–11 analyst PT…

Coal-policy sympathy squeeze, now three days old with no follow-through: SXC sits at its 52-wk high $9.69 (~+75% off the $5.52 low), RSI ~80, after Trump's 2026-06-03 $700M coal package funding that lands on an Oakland export terminal and…

Legacy touch/display semi re-rating as edge-AI silicon: Core IoT +31% YoY (Q3, 5/7) toward FY26 >+40%/>$385M, plus a Google Research Coralboard/Coral NPU tie-up at I/O 2026. Narrative accelerating, but the easy leg ran $58→$149 and there's…

Legacy open-web ad network repricing as an agentic-AI platform on a Q1 beat-and-raise (2026-05-07), but only ~6% FY26 growth and a ~$77M one-time legal windfall flatter the print. Near-term edge is mechanical Russell 2000/3000 inclusion…

Cyber laggard: single-digit grower (+9.6%), busted chart below 50/200-DMA, only hook is undated take-private speculation. Value-trap / deal-headline name, not momentum WATCH.

Workforce-housing small cap re-rated into an AI data-center landlord after a 2026-04-01 multi-year lease with a top-five hyperscaler for a North Texas campus; FY26 guide lifted to $360–370M and the stock roughly doubled off its $8–12 base.…

Value-based oncology turnaround inflecting to first-ever profitability: Q1'26 revenue +41% YoY, Florida capitation now profitable, FY26 adj-EBITDA guide $0–9M. Tripled off $2.02; a 10% owner keeps buying (12k sh @ $4.75, Jun 5). Real,…

Spatial-biology re-rate but Atera revenue is a 2027 story, Q1 -3% YoY, -7.3% outside-reversal off the high stretched, post-catalyst, idiosyncratic.

Q1 print (reported 2026-05-11) resolved the binary benignly: $987.5M combined revenue, FY2026 guide reaffirmed at $3.63B rev / $1.45B adj EBITDA, net loss on $188M quarterly interest. Story shifts from pre-print coin-flip to a…

Hillary Super turnaround confirmed by a +47% earnings blowoff (Q1 adj EPS $0.60 vs $0.32, comps +13%, FY op-income guide hiked to $550–580M). But the catalyst has fired and the June-11 proxy fight resolved in management's favor narrative…

Deep-cyclical trailer OEM at trough Q1'26 sales −20% YoY, negative gross margin, net debt > market cap. Backlog turned up to $837M (+$132M q/q) on a fragile freight recovery, but price sits near 52-week lows with no breakout a…

Activist-anchored distressed deleveraging: STARTEEPO Invest at 6.22% (3rd-largest holder, 13D/A 2026-06-01) bets Lexmark synergies + a 7x→3x leverage compression re-rate the levered equity. The 2026-06-04 pop to $3.49 has stalled near…